Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

First interim dividend

17 Jan 2025 17:14

RNS Number : 8458T
Experian plc
17 January 2025
 

Experian plc

 

 

First interim dividend - exchange rate and Irish dividend withholding tax

 

 

17 January 2025 - Experian plc, the global information services company, hereby notifies the market that, further to the announcement on 13 November 2024 of a first interim dividend of 19.25 US cents per ordinary share payable on 7 February 2025 to shareholders on the register of members at the close of business on 10 January 2025, the exchange rate to be used to convert the dividend payment from US dollars to sterling pounds, for those shareholders who did not elect by 10 January 2025 to receive payment in US dollars, will be £1 = $1.21984 Accordingly, the sterling amount of dividend payable on 7 February 2025 to such shareholders will be approximately 15.7807 pence per share.

 

Shareholders who did not elect to receive UK sourced dividends through the income access share arrangements are reminded that, as previously advised, their dividends will be subject to Irish dividend withholding tax unless the Company's Registrars are in possession of a valid exemption form. As previously advised, the final date for submission of elections to receive UK sourced dividends via the income access share arrangements was 10 January 2025. In the absence of any such elections, previous elections or deemed elections will remain in force.

 

Contact:

 

Experian

Charles Brown

Company Secretary

+353 (0) 86 819 4473

 

 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVFLFLDLFIDLIE
Date   Source Headline
18th Mar 20214:40 pmRNSDirector Declaration
10th Mar 20219:15 amRNSAdditional Listing
26th Feb 20212:26 pmRNSTotal Voting Rights
17th Feb 202110:53 amRNSBlock listing
8th Feb 20217:00 amRNSResponse to media speculation in Brazil
29th Jan 20213:03 pmRNSTotal Voting Rights
19th Jan 20217:00 amRNSExperian plc, Trading update, third quarter
15th Jan 20215:45 pmRNSFirst interim dividend
4th Jan 202111:16 amRNSTotal Voting Rights
18th Dec 202011:00 amRNSElections for first interim dividend
9th Dec 202010:00 amRNSAdditional Listing
30th Nov 20203:40 pmRNSTotal Voting Rights
26th Nov 202011:30 amRNSLong-Term Incentive Plans – Performance Measures
25th Nov 20209:39 amRNSAdditional Listing
17th Nov 20203:36 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSHalf-year Report
30th Oct 20203:14 pmRNSTotal Voting Rights
27th Oct 202012:32 pmRNSUK marketing services - ICO enforcement notice
21st Oct 20209:08 amRNSAdditional Listing
30th Sep 20202:17 pmRNSTotal Voting Rights
28th Sep 20206:15 pmRNSBond Issue
25th Sep 202012:30 pmRNSHolding(s) in Company
23rd Sep 202012:02 pmRNSDirector/PDMR Shareholding
18th Sep 20202:58 pmRNSBlock listing Interim Review
9th Sep 20209:22 amRNSAdditional Listing
8th Sep 20207:00 amRNSTrading update, Q2 revenue expectations revised
1st Sep 202010:25 amRNSTotal Voting Rights
28th Aug 202010:00 amRNSDirector/PDMR Shareholding
26th Aug 20209:15 amRNSAdditional Listing
19th Aug 20206:01 pmRNSExperian South Africa curtails fraud incident
19th Aug 20209:12 amRNSAdditional Listing
31st Jul 202012:55 pmRNSTotal Voting Rights
31st Jul 202012:00 pmRNSDirector/PDMR Shareholding
22nd Jul 202011:38 amRNSResult of AGM
16th Jul 20207:00 amRNSExperian PLC Trading update, first quarter
3rd Jul 20205:41 pmRNSSecond Interim Dividend
1st Jul 20202:00 pmRNSDirectorate Change
30th Jun 20202:53 pmRNSTotal Voting Rights
24th Jun 202012:25 pmRNSAdditional Listing
19th Jun 20204:40 pmRNSSecond Price Monitoring Extn
19th Jun 20204:35 pmRNSPrice Monitoring Extension
12th Jun 20202:50 pmRNSAnnual Financial Report
12th Jun 20202:20 pmRNSDirector/PDMR Shareholding
10th Jun 20203:30 pmRNSDirector/PDMR Shareholding
8th Jun 202010:35 amRNSTransaction in Own Shares
5th Jun 202012:57 pmRNSElections for second interim dividend
29th May 202012:32 pmRNSTotal Voting Rights
27th May 202011:25 amRNSAdditional Listing
20th May 20207:00 amRNSFull-year financial report
30th Apr 202012:06 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.